MedTrace Logo

Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking

NCT02514512 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-02-06

No results posted yet for this study

Summary

A research study into a new technology for adjustment of the radiotherapy beam to account for movement of lung tumours as the patient breathes during radiotherapy.

Conditions

  • Neoplasms
  • Lung Neoplasms

Interventions

DEVICE

MLC Tracking

Treat patient with Non FDA approved MLC Tracking

Sponsors & Collaborators

  • University of Sydney

    collaborator OTHER

  • Varian Medical Systems

    collaborator INDUSTRY

  • Royal North Shore Hospital

    lead OTHER

Principal Investigators

  • Thomas Eade, MD · RNSH

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2023-11-30
Completion
2026-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02514512 on ClinicalTrials.gov